International Society of Amyloidosis (ISA), a non-profit organization of Scientists and Physicians engaged in research, teaching, or practice in connection with amyloid and amyloidosis. The aims of our Society are to promote research, education, clinical studies (including diagnosis and treatment), conferences and symposia on all aspects of amyloidosis worldwide.
As you are all aware, the meeting was postponed from its original March 2020 dates, to September 14-18, 2020 due to the COVID-19 pandemic. Despite our hope for a physical meeting, we realize that this is not possible due to present circumstances - Particularly due to travel restrictions, and also to social distancing guidelines.
The decision has been made to hold the XVII ISA Symposium on a virtual platform, maintaining the week of September 14, 2020. More information to follow.
We regret any inconvenience that this change may cause, and we thank you for your understanding.
A PDF version of the program can be found here.
Watch this space for information regarding the ISA 2020 meeting in Tarragona Spain.
The current Board of Directors of the ISA was officially elected for the next term via electronic vote on March 4, 2020.
Since 2002, the ISA has had exceptional leadership from around the world. We value their dedication and efforts that have led the organization in progressing the advancement of amyloidosis research.
Amyloid fibrils are structures in which misfolded proteins are deposited in tissue and organs. Different proteins can be deposited as amyloid in various sites of the human body. When in a piece of tissue (a so-called biopsy) these deposits are viewed under a microscope in normal light, the material looks amorphous. However, if the same deposits are viewed under an electron microscope with higher magnification, massive amounts of small non-branching amyloid fibrils can be seen. When a biopsy is stained with Congo red dye, the deposits will stain red. A characteristic feature of amyloid is that these red deposits will turn into apple green if viewed in polarized light. When amyloid deposition leads to signs and symptoms of disease it is called amyloidosis.